Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00997854
Other study ID # 5376
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2009
Est. completion date October 2010

Study information

Verified date June 2019
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Doctors have tried many different methods of feeding to try to decrease feeding intolerance in preterm babies so that they spend less time receiving liquid nutrition and have fewer problems with feeding intolerance.

The purpose of this study is to test two different methods of feeding preterm babies in the hopes of identifying a method that will decrease some of the feeding intolerance that can occur when feeding premature babies.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 32 Weeks
Eligibility Inclusion Criteria:

- Any infant born at OHSU or transferred in from another facility whose birthweight is greater than 500 grams and less than 1500 grams, and whose gestational age is less than 32 weeks.

Exclusion Criteria:

- Any infant who has major anomalies including but not limited to *gastroschisis

- omphalocele

- bowel obstruction or atresia

- tracheo-esophageal fistula

- Hirschsprung's Disease

- congenital diaphragmatic hernia

- congenital heart disease and other major syndromes

- infants who have started enteral feeds prior to entering the study

- Any infant whose birth weight is greater than or equal to 1500 grams or less than 500 grams

- Any infant whose gestational age is greater than 32 weeks.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Length of time for feed administration
Group 1 will consist of babies fed by bolus method, administered over no more than 30 minutes. Group 2 will be fed by slow infusion by pump over 2 hours.

Locations

Country Name City State
United States Oregon Health & Sciences University Portland Oregon

Sponsors (1)

Lead Sponsor Collaborator
Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To compare feeding intolerance between these two groups as defined by the following criteria: the number of times that the signs and symptoms in an infant caused the perception of feeding intolerance with feeds paused for longer than one feeding. Daily
Secondary To compare the number of days it takes the infant to reach full feeds. After reaching full feeds.
Secondary To compare the number of days the infant requires intravenous nutrition. After reaching full feeds.
Secondary To compare the number of days of overall hospitalization duration. After patient discharge.
See also
  Status Clinical Trial Phase
Terminated NCT03320785 - Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Completed NCT02980250 - Multi-Center Study of Different Doses Domperidone in Feeding Intolerance Phase 4
Not yet recruiting NCT02534090 - Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy N/A
Recruiting NCT02149407 - Glycerin Suppositories for Treatment of Feeding Intolerance in Preterm Infants N/A
Completed NCT03822104 - Bovine Colostrum as a Human Milk Fortifier for Preterm Infants N/A
Recruiting NCT05347706 - Protocol for Feeding Intolerance in Preterm Infants N/A
Completed NCT00331201 - SAFEstart Feeding Intolerance Study Phase II Phase 2
Recruiting NCT02598375 - Evaluation of Status of Early Reached Target Enteral Nutrition and IFABP as Biomarker of Feeding Intolerance in Critically Ill Children N/A
Terminated NCT02028156 - Feeding Intolerance in Formula-Fed Infants N/A
Completed NCT01191112 - Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population Phase 3
Completed NCT01441427 - Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial Phase 1/Phase 2
Completed NCT01987154 - Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula N/A
Completed NCT02054091 - Feeding Bovine Colostrum to Preterm Infants N/A
Recruiting NCT00450697 - Feeding Tolerance in Preterm Infants N/A
Completed NCT03537365 - Bovine Colostrum as a Fortifier Added to Human Milk for Preterm Infants N/A
Completed NCT04304807 - Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants Phase 4
Not yet recruiting NCT00550069 - Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year N/A
Not yet recruiting NCT04950738 - The Effectiveness of Acupuncture for Complications in Critically Ill Patients N/A